FDA Inspection 1178934 — Busan Paik Hospital
The FDA completed an inspection of Busan Paik Hospital on May 20, 2022 in Busan. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 20, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Busan (Korea (the Republic of))
Additional Details
Clinical BA/BE